Apricus Announces Laboratoires Majorelle to Market Vitaros in France, Monaco and Certain African Countries
November 13, 2013 at 06:25 AM EST
Apricus Biosciences (NASDAQ: APRI ) announced today that Apricus signed an exclusive license agreement with Laboratoires Majorelle to market Vitaros®, its topical on-demand product for the treatment of erectile dysfunction ("ED"), in France, Monaco and certain African countries (the "Territory"). Under the terms of the agreement, Apricus is eligible to